275 related articles for article (PubMed ID: 17255135)
41. Decreased live births in women with systemic lupus erythematosus.
Vinet E; Clarke AE; Gordon C; Urowitz MB; Hanly JG; Pineau CA; Isenberg D; Rahman A; Wallace D; Alarcón GS; Bruce I; Petri M; Dooley MA; Kalunian K; Maddison P; Aranow C; van Vollenhoven R; Bernatsky S
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1068-72. PubMed ID: 21425248
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
Teta MJ; Lau E; Sceurman BK; Wagner ME
Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
[TBL] [Abstract][Full Text] [Related]
43. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.
Costenbader KH; Kim DJ; Peerzada J; Lockman S; Nobles-Knight D; Petri M; Karlson EW
Arthritis Rheum; 2004 Mar; 50(3):849-57. PubMed ID: 15022327
[TBL] [Abstract][Full Text] [Related]
44. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
[TBL] [Abstract][Full Text] [Related]
45. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.
Card TR; West J; Holmes GK
Aliment Pharmacol Ther; 2004 Oct; 20(7):769-75. PubMed ID: 15379837
[TBL] [Abstract][Full Text] [Related]
46. HL-A histocompatibility antigens and their relation to disease.
Lange CF
Prog Clin Pathol; 1975; 6():137-62. PubMed ID: 1105669
[TBL] [Abstract][Full Text] [Related]
47. [Risk factors for Hodgkin's lymphomas].
Ferrís Tortajada J; García Castell J; López Andreu JA; Clar Gimeno S; Berbel Tornero O
An Esp Pediatr; 2001 Sep; 55(3):239-43. PubMed ID: 11676899
[TBL] [Abstract][Full Text] [Related]
48. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
50. [Systemic lupus erythematosus in the county of Fynen. An epidemiologic study].
Voss AB; Green A; Junker P
Ugeskr Laeger; 1999 Jun; 161(25):3837-40. PubMed ID: 10412302
[TBL] [Abstract][Full Text] [Related]
51. Hodgkins lymphoma in North Jordan. Does it have a different pattern?
Almasri NM
Saudi Med J; 2004 Dec; 25(12):1917-21. PubMed ID: 15711667
[TBL] [Abstract][Full Text] [Related]
52. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
53. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
54. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management.
Eilertsen GØ; Becker-Merok A; Nossent JC
J Rheumatol; 2009 Mar; 36(3):552-9. PubMed ID: 19208593
[TBL] [Abstract][Full Text] [Related]
55. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.
Hjalgrim H; Ekström-Smedby K; Rostgaard K; Amini RM; Molin D; Hamilton-Dutoit S; Schöllkopf C; Chang ET; Ralfkiaer E; Adami HO; Glimelius B; Melbye M
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1561-6. PubMed ID: 17684129
[TBL] [Abstract][Full Text] [Related]
56. Factors associated with abnormal Pap results in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Joseph L; Boivin JF; Rajan R; Allen A; Moore AD; Leung MH; Clarke A
Rheumatology (Oxford); 2004 Nov; 43(11):1386-9. PubMed ID: 15280571
[TBL] [Abstract][Full Text] [Related]
57. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.
Becker-Merok A; Nossent J
Lupus; 2009 May; 18(6):508-15. PubMed ID: 19395452
[TBL] [Abstract][Full Text] [Related]
58. The outcome of renal transplantation among systemic lupus erythematosus patients.
Chelamcharla M; Javaid B; Baird BC; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2007 Dec; 22(12):3623-30. PubMed ID: 17640941
[TBL] [Abstract][Full Text] [Related]
59. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.
Sánchez E; Abelson AK; Sabio JM; González-Gay MA; Ortego-Centeno N; Jiménez-Alonso J; de Ramón E; Sánchez-Román J; López-Nevot MA; Gunnarsson I; Svenungsson E; Sturfelt G; Truedsson L; Jönsen A; González-Escribano MF; Witte T; ; Alarcón-Riquelme ME; Martín J
Arthritis Rheum; 2007 Sep; 56(9):3080-6. PubMed ID: 17763438
[TBL] [Abstract][Full Text] [Related]
60. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
